Stockholders' Deficit (Tables)

12 Months Ended

Dec. 31, 2017

Equity [Abstract]

Schedule of Stock Options Warrants

The following table summarizes information about warrants granted during the years ended December 31, 2017 and 2016:

	December 31, 2017				December 31, 2016
	Number of warrants		Weighted Average Exercise Price		Number of warrants			Weighted Average Exercise Price
Balance, beginning of year		1,405,000		0.52		1,410,000			0.52
Warrants granted		4,500,000		0.17		-			-
Warrants expired		-		-		(5,000	)		(1.00	)
Warrants cancelled, forfeited		-		-		-			-
Warrants exercised		-		-		-			-
Balance, end of year		5,905,000		0.25		1,405,000			0.52
Exercisable warrants		4,780,000		0.29		1,405,000			0.52

Schedule of Outstanding Warrants

Outstanding warrants as at December 31, 2017 are as follows:

Range of Exercise Prices		Weighted Average residual life span (in years)		Outstanding Warrants		Weighted Average Exercise Price		Exercisable Warrants		Weighted Average Exercise Price
	0.11		3.59		1,500,000		0.11		375,000		0.11
	0.20		3.0		3,000,000		0.20		3,000,000		0.20
	0.25		0.25		900,000		.25		900,000		0.25
	1.00		0.33		505,000		1.00		505,000		1.00
	0.11 to 1.00		2.50		5,905,000		0.25		4,780,000		0.29

Schedule of Warrants Outstanding, Expiry Date and Exercise Prices

Warrants outstanding at the end of the year have the following expiry date and exercise prices:

Expiry Date	Exercise Prices		December 31, 2017		December 31, 2016
March 22, 2018		1.00		300,000		300,000
April 1, 2018		0.25		900,000		900,000
April 30, 2018		1.00		5,000		5,000
July 10, 2018		1.00		200,000		200,000
December 30, 2020		0.20		3,000,000		-
August 2,2021		0.11		1,500,000		-
				5,905,000		1,405,000

Schedule of Stock Options Granted

The following table summarizes information about stock options granted during the years ended December 31, 2017 and 2016:

	December 31, 2017					December 31, 2016
	Number of stock options		Weighted Average Exercise Price			Number of stock options			Weighted Average Exercise Price
Balance, beginning of year		2,644,000		0.50			6,044,000			0.50
Stock options granted		6,981,000		0.10			-			-
Stock options expired		-		-			-			-
Stock options cancelled, forfeited		-		(0.50	)		(3,400,000	)		(0.50	)
Stock options exercised		-		-			-			-
Balance, end of year		9,625,000		0.21			2,644,000			0.49
Exercisable stock options		6,010,583		0.25			1,925,250			0.49

Schedule of Outstanding Stock Options

Outstanding stock options as at December 31, 2017 are as follows:

Range of Exercise Prices		Weighted Average residual life span (in years)		Outstanding Stock Options		Weighted Average Exercise Price		Exercisable Stock Options		Weighted Average Exercise Price
	0.075 to 0.09		4.16		2,981,000		0.08		1,460,333		0.08
	0.11		3.59		3,500,000		0.11		1,750,000		0.11
	0.145		9.76		500,000		0.145		500,000		0.145
	0.33 to 0.38		0.29		144,000		0.36		144,000		0.36
	0.50		6.89		2,500,000		0.50		2,156,250		0.50
	0.075 to 0.50		4.9		9,625,000		0.21		6,010,583		0.25

Schedule of Stock Options, Expiry Date and Exercise Prices

Stock options outstanding at the end of the year have the following expiry date and exercise prices:

Expiry Date	Exercise Prices		December 31, 2017		December 31, 2016
February 26, 2018		0.37		72,000		72,000
April 27, 2018		0.38		36,000		36,000
July 9, 2018		0.33		36,000		36,000
August 2, 2021		0.11		3,500,000		-
February 17, 2022		0.09		2,281,000		-
March 30, 2022		0.09		700,000		-
November 20, 2024		1.00		2,500,000		2,500,000
October 2, 2027		0.145		500,000		-
				9,625,000		2,644,000

Summary of Stock Compensation Expense

For the year ending December 31, 2017 and December 31, 2016, the Company recorded stock compensation expense relating to the vesting of stock options as follows;

	December 31,
	2017		2016
Board compensation expense	$	8,181	$	28,880
Stock compensation		56,400		273,443
Stock Option vesting		686,164		73,128
Total	$	750,745	$	375,451